125 related articles for article (PubMed ID: 1537074)
41. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
Borsellino N; Belldegrun A; Bonavida B
Cancer Res; 1995 Oct; 55(20):4633-9. PubMed ID: 7553641
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA.
Chan JY; Chu AC; Fung KP
Life Sci; 2000 Sep; 67(17):2117-24. PubMed ID: 11057761
[TBL] [Abstract][Full Text] [Related]
43. Amplification and expression of a multidrug resistance gene in human glioma cell lines.
Matsumoto T; Tani E; Kaba K; Kochi N; Shindo H; Yamamoto Y; Sakamoto H; Furuyama J
J Neurosurg; 1990 Jan; 72(1):96-101. PubMed ID: 2294193
[TBL] [Abstract][Full Text] [Related]
44. Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma.
Tong AW; Su D; Mues G; Tillery GW; Goldstein R; Klintmalm G; Stone MJ
Clin Cancer Res; 1996 Mar; 2(3):531-9. PubMed ID: 9816200
[TBL] [Abstract][Full Text] [Related]
45. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
47. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
48. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
49. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents.
Kohno K; Sato S; Takano H; Matsuo K; Kuwano M
Biochem Biophys Res Commun; 1989 Dec; 165(3):1415-21. PubMed ID: 2575381
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection.
Chen KG; Jaffrézou JP; Fleming WH; Durán GE; Sikic BI
Cancer Res; 1994 Sep; 54(18):4980-7. PubMed ID: 7915196
[TBL] [Abstract][Full Text] [Related]
51. Establishment of multidrug resistant human colorectal carcinoma HCT-15 cell lines and their properties.
Iwahashi T; Okochi E; Ono K; Sugawara I; Tsuruo T; Mori S
Anticancer Res; 1991; 11(3):1309-12. PubMed ID: 1679619
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines.
Minemura M; Tanimura H; Tabor E
Int J Oncol; 1999 Sep; 15(3):559-63. PubMed ID: 10427140
[TBL] [Abstract][Full Text] [Related]
53. Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma.
Chen KG; Lacayo NJ; Durán GE; Wang Y; Bangs CD; Rea S; Kovacs M; Cherry AM; Brown JM; Sikic BI
Genes Chromosomes Cancer; 2002 Aug; 34(4):372-83. PubMed ID: 12112526
[TBL] [Abstract][Full Text] [Related]
54. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.
Yang CZ; Luan FJ; Xiong DS; Liu BR; Xu YF; Gu KS
Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):333-7. PubMed ID: 7668104
[TBL] [Abstract][Full Text] [Related]
55. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J
Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127
[TBL] [Abstract][Full Text] [Related]
56. Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity.
Keith WN; Stallard S; Brown R
Br J Cancer; 1990 May; 61(5):712-6. PubMed ID: 1970934
[TBL] [Abstract][Full Text] [Related]
57. Reversal of multidrug resistance by magnetic chitosan-Fe₃O₄ nanoparticle-encapsulated MDR₁ siRNA in glioblastoma cell line.
Zhao P; Wang H; Gao H; Li C; Zhang Y
Neurol Res; 2013 Oct; 35(8):821-8. PubMed ID: 23651652
[TBL] [Abstract][Full Text] [Related]
58. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
[TBL] [Abstract][Full Text] [Related]
59. Multidrug resistance-associated protein gene expression and drug sensitivity in human lung cancer cells.
Narasaki F; Oka M; Fukuda M; Ikeda K; Terashi K; Takatani H; Nakamura T; Soda H; Kohno S
Anticancer Res; 1997; 17(5A):3493-7. PubMed ID: 9413193
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of MDR1 gene expression by H-87, a selective inhibitor of cAMP-dependent protein kinase.
Kim SH; Park JI; Chung BS; Kang CD; Hidaka H
Cancer Lett; 1993 Oct; 74(1-2):37-41. PubMed ID: 8287370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
